Miho Kanda

1.1k total citations
15 papers, 759 citations indexed

About

Miho Kanda is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Miho Kanda has authored 15 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 9 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Miho Kanda's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Miho Kanda is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Miho Kanda collaborates with scholars based in Japan and United States. Miho Kanda's co-authors include Masao Omata, Ryosuke Tateishi, Shuichiro Shiina, Haruhiko Yoshida, Shuntaro Obi, Tadashi Goto, Ryota Masuzaki, Yuji Kondo, Kazuhiko Koike and Koji Uchino and has published in prestigious journals such as Gastroenterology, Cancer and Liver International.

In The Last Decade

Miho Kanda

13 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miho Kanda Japan 9 567 282 200 187 172 15 759
A. Baldan Italy 7 647 1.1× 162 0.6× 306 1.5× 137 0.7× 121 0.7× 10 862
O Nakashima Japan 16 498 0.9× 221 0.8× 286 1.4× 163 0.9× 108 0.6× 30 792
Jie Mei China 18 525 0.9× 211 0.7× 212 1.1× 263 1.4× 151 0.9× 51 898
Roberto Ragazzi Italy 7 366 0.6× 176 0.6× 125 0.6× 109 0.6× 200 1.2× 14 591
Wen‐Feng Gong China 14 800 1.4× 277 1.0× 436 2.2× 324 1.7× 156 0.9× 29 1.1k
Sheung-Tat Fan Hong Kong 6 723 1.3× 412 1.5× 403 2.0× 189 1.0× 240 1.4× 6 1.0k
Ken Takasaki Japan 10 397 0.7× 256 0.9× 158 0.8× 173 0.9× 178 1.0× 15 808
Jong Young Choi South Korea 18 899 1.6× 315 1.1× 397 2.0× 171 0.9× 170 1.0× 33 1.1k
Fuyo Yoshimi Japan 16 404 0.7× 487 1.7× 183 0.9× 461 2.5× 315 1.8× 61 1.1k
Takumi Irie Japan 17 271 0.5× 189 0.7× 181 0.9× 303 1.6× 90 0.5× 42 674

Countries citing papers authored by Miho Kanda

Since Specialization
Citations

This map shows the geographic impact of Miho Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miho Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miho Kanda more than expected).

Fields of papers citing papers by Miho Kanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miho Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miho Kanda. The network helps show where Miho Kanda may publish in the future.

Co-authorship network of co-authors of Miho Kanda

This figure shows the co-authorship network connecting the top 25 collaborators of Miho Kanda. A scholar is included among the top collaborators of Miho Kanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miho Kanda. Miho Kanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Obi, Shuntaro, Takahisa Sato, Shinpei Sato, et al.. (2019). The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting. Hepatology International. 13(2). 199–204. 26 indexed citations
3.
Ooka, Yoshihiko, Miho Kanda, Shuntaro Obi, et al.. (2018). Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection. Hepatology International. 12(6). 523–530. 18 indexed citations
4.
5.
Kawai, Toshihiro, Yoko Yashima, Takafumi Sugimoto, et al.. (2016). Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study. World Journal of Surgical Oncology. 14(1). 52–52. 7 indexed citations
6.
Yashima, Yoko, Shinpei Sato, Toshihiro Kawai, et al.. (2014). Intraarterial 5-fluorouracil and interferon therapy is safe and effective for nonresectable biliary tract adenocarcinoma. Hepatology International. 9(1). 142–148. 5 indexed citations
7.
Uchino, Koji, Shuntaro Obi, Ryosuke Tateishi, et al.. (2012). Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma. Journal of Gastroenterology. 47(10). 1152–1159. 10 indexed citations
8.
Uchino, Koji, Ryosuke Tateishi, Shuichiro Shiina, et al.. (2011). Hepatocellular carcinoma with extrahepatic metastasis. Cancer. 117(19). 4475–4483. 306 indexed citations
9.
Kanda, Miho, Ryosuke Tateishi, Haruhiko Yoshida, et al.. (2008). Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors. Liver International. 28(9). 1256–1263. 103 indexed citations
10.
Koike, Yukihiro, Haruhiko Yoshida, Shuichiro Shiina, et al.. (2007). Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesion. Hepatology International. 1(2). 295–301. 11 indexed citations
11.
Fujishima, Tomonori, Takashi Ishikawa, Yasushi Shiratori, et al.. (2007). Age-related comparison of the profiles of patients with hepatocellular carcinoma.. PubMed. 53(72). 913–8. 7 indexed citations
12.
Obi, Shuntaro, Haruhiko Yoshida, Tadao Unuma, et al.. (2006). Combination therapy of intraarterial 5‐fluorouracil and systemic interferon‐alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer. 106(9). 1990–1997. 212 indexed citations
13.
Fujishima, Tomonori, Haruhiko Yoshida, Shuntaro Obi, et al.. (2005). Analysis of factors influencing hepatocellular carcinoma detection: efficient use of computed tomography during arterial portography and during hepatic arteriography. Journal of Gastroenterology. 40(3). 266–273. 12 indexed citations
14.
Tanaka, Yasuo, Masaki Takayanagi, Yasushi Shiratori, et al.. (2003). Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver. Journal of Gastroenterology. 38(3). 288–294. 41 indexed citations
15.
Tateishi, Ryosuke, Haruhiko Yoshida, Shuichiro Shiina, et al.. (2003). Proposal of A new prognostic model for hepatocellular carcinomaȁTokyo Score. Gastroenterology. 124(4). A708–A708. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Baldan Breakdown of academic impact, for papers by O Nakashima Breakdown of academic impact, for papers by Jie Mei Breakdown of academic impact, for papers by Roberto Ragazzi Breakdown of academic impact, for papers by Wen‐Feng Gong Breakdown of academic impact, for papers by Sheung-Tat Fan Breakdown of academic impact, for papers by Ken Takasaki Breakdown of academic impact, for papers by Jong Young Choi Breakdown of academic impact, for papers by Fuyo Yoshimi Breakdown of academic impact, for papers by Takumi Irie
Rankless by CCL
2026